The use of phthoxazolin A, which acts as a small-molecule modulator of tumor–stromal cell interactions, can indirectly suppress PC cancer cell growth through inhibition of IGF-I production by prostate stromal cells [509]. This evidence concerns the gene IGF1 and neoplasm.